These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

87 related articles for article (PubMed ID: 7434726)

  • 21. [Effect of a natural interferon inducer (RFf2) on the formation of vaccinal immunity to tick-borne encephalitis].
    Fomina AN; Nosik NN; Bukata LA; Davydova AA; Barinskiĭ NF
    Antibiotiki; 1979 Jan; 24(1):67-71. PubMed ID: 426497
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Effect of a poly I-poly C complex with poly-L-lysine on experimental tick-borne encephalitis].
    Burgasova MP; Andzhaparidze OG; Bektemirov TA; Bogomolova NN; Boriskin IuS
    Vopr Virusol; 1977; (4):438-41. PubMed ID: 411260
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Investigation of the anti-viral mechanism of poly I and poly C against encephalomyocarditis virus infection in the absence of interferon induction in mice.
    Stebbing N; Grantham CA; Kaminski F
    J Gen Virol; 1976 Jul; 32(1):25-35. PubMed ID: 182913
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Effect of virazole on the antiviral activity of poly(G) X poly(C) and other polyribonucleotide interferonogens].
    Vil'ner LM; Lashkevich VA
    Antibiotiki; 1984 Jun; 29(6):450-3. PubMed ID: 6089650
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Target-organ treatment of neurotropic virus disease with interferon inducers.
    Allen LB; Cochran KW
    Infect Immun; 1972 Nov; 6(5):819-23. PubMed ID: 4404669
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [General considerations on the interferon system].
    Pugliese A
    G Batteriol Virol Immunol; 1979; 72(1-6):78-114. PubMed ID: 95450
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Antiviral activity of yeast dsRNA in experimental infection caused by the human acute encephalomyelitis virus].
    Ignat'ev GM; Gribencha SV; Tazulakhova EB; Barinskiĭ IF
    Vopr Virusol; 1988; 33(2):251-3. PubMed ID: 3414074
    [No Abstract]   [Full Text] [Related]  

  • 28. Efficacy of trivalent inactivated encephalomyelitis virus vaccine in horses.
    Barber TL; Walton TE; Lewis KJ
    Am J Vet Res; 1978 Apr; 39(4):621-5. PubMed ID: 646197
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Enhancement of interferon induction in mice by polycationic modified polypeptides.
    Mécs I; Gánti T; Kótai A
    Acta Virol; 1976 Apr; 20(2):164-6. PubMed ID: 5874
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Formation and action of interferon in experimental respiratory syncytial infection].
    Grodnitskaia NA; Dreĭzin RS; Etkind GV; Bektemirov TA
    Vopr Virusol; 1975; (3):305-9. PubMed ID: 1162951
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Effect of exogenous interferon and an interferon inducer on western equine encephalitis virus disease in a hamster model.
    Julander JG; Siddharthan V; Blatt LM; Schafer K; Sidwell RW; Morrey JD
    Virology; 2007 Apr; 360(2):454-60. PubMed ID: 17118420
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Antiviral effects of double-stranded RNA from rice dwarf virus on infection of mice with western equine encephalitis virus.
    Takehara M
    Microbiol Immunol; 1977; 21(6):309-15. PubMed ID: 333233
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Therapy of murine rabies after exposure: efficacy of polyriboinosinic-polyribocytidylic acid alone and in combination with three rabies vaccines.
    Harmon MW; Janis B
    J Infect Dis; 1975 Sep; 132(3):241-9. PubMed ID: 1159327
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Combined antiviral effect of synthetic polyribonucleotide interferonogens and specific antiviral antibodies in arbovirus infections].
    Vil'ner LM; Lashkevich VA; Tikhomirova-Sidorova NS; Kogan EM; Timkovskiĭ AL
    Vopr Virusol; 1984; 29(3):334-7. PubMed ID: 6464427
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Interferon: effects on the immune response and the mechanism of activation of the cellular response.
    Johnson HM; Baron S
    CRC Crit Rev Biochem; 1976 Nov; 4(2):203-27. PubMed ID: 12914
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Effect of polyene antibiotics on the increase in specific resistance due to inactivated antiviral vaccines].
    Vil'ner LM; Ral'f NM; Finogenova EV; Shneĭder MA; Tereshin IM
    Antibiotiki; 1980 Sep; 25(9):669-73. PubMed ID: 7416734
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The clinical implications of human interferon.
    Cesario TC
    Med Clin North Am; 1983 Sep; 67(5):1147-62. PubMed ID: 6413792
    [No Abstract]   [Full Text] [Related]  

  • 38. Transmissibility of an attenuated Venezuelan equine encephalomyelitis vaccine virus.
    Taylor WM; Buff E
    J Am Vet Med Assoc; 1972 Jul; 161(2):159-63. PubMed ID: 4402529
    [No Abstract]   [Full Text] [Related]  

  • 39. [Indices of lymphocyte functional activity in patients with recurrent cutaneous-genital herpes during treatment with a herpes vaccine].
    Karpovich LG; Blokha VV; Kalashnikova TV; Bychkova AA; Semenova TB
    Vopr Virusol; 1986; 31(2):200-5. PubMed ID: 3014750
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Post-exposure prophylaxis of murine rabies with polyinosinic-polycytidylic acid and chlorite-oxidized amylose.
    Harmon MW; Janis B; Levy HB
    Antimicrob Agents Chemother; 1974 Oct; 6(4):507-11. PubMed ID: 4157354
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.